MedPath

Multicentric Study Comparing Carcinological and Functional Results of Surgery

Phase 3
Conditions
Cancer of the PROSTATE
Interventions
Procedure: Radical laparoscopy prostatectomy
Procedure: Radical retropubic prostatectomy
Registration Number
NCT00502723
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

National multicentric prospective open study, comparing two current surgical methods: laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.

Detailed Description

The aim of this study is to show that radical prostatectomy by laparoscopic way could obtain carcinological results not lower than theses with radical retropubic surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
1440
Inclusion Criteria
  • Male, old patient of less than 70 years,
  • having a prostate cancer proven histologically, requiring a radical prostatectomy.
  • Clinical stage T1c and rate of PSA (with 20 ng/ml).
  • Osseous scintiscanning and abdomen-pelvic scanner negative.
  • Patient informed of the study and its participation.
  • Patient affiliated to a social security system.
Read More
Exclusion Criteria
  • Contra-indication with the surgery or the anaesthesia.
  • Antecedent of prostate resection or adenomectomy.
  • Antecedent of inguinal hernia treatment.
  • Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
  • Patient privatized of freedom.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2Radical laparoscopy prostatectomyRadical laparoscopy prostatectomy
1Radical retropubic prostatectomyRadical retropubic prostatectomy
Primary Outcome Measures
NameTimeMethod
laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.during the study
Secondary Outcome Measures
NameTimeMethod
Carcinological (percentage of positive surgical margins, percentage of capsular crossing).after the surgical
Functional (urinary continence, sexuality, quality of life)at 2 years
per and post operational morbidityduring the 36 months
economicduration and cost of hospitalization

Trial Locations

Locations (1)

Groupe Hospitalier Albert Chenevier Henri Mondor

🇫🇷

Creteil, France

© Copyright 2025. All Rights Reserved by MedPath